Drug delivery inspired by spiky sponges

C.F. van der Walle

Research output: Contribution to journalArticle

Abstract

Silica materials are of interest in biotechnology and drug delivery (Giri et al 2007) but controllable silicate formation is very difficult. Yet a variety of sponge species make highly ordered specific glass structures called spicules (Shimizu et al 1998). Harnessing the processes that underlie this biosynthesis has considerable application. The enzyme silicatein forms part of the organic filament found in spicules, which condenses silicate in situ. Both wild-type and recombinant silicatein have been shown to catalyse the condensation of siloxanes such as tetraethoxysilane (Cha et al 1999). However, neither the wild-type nor recombinant silicatein are amenable to biophysical study due to low levels of protein expression and inclusion body formation when recombinantly expressed in Escherichia coli. We recently reported silicatein -cathepsin L chimaeras with the ability to condense silica from solution. These chimaeras are readily obtained by expression in Pichia pastoris, with yields around 40 mg/L of culture. The 1.5 A ° crystal structure of one of these chimaeras allows us to rationalize the catalytic mechanism of silicic acid condensation (Fairhead et al 2008). This is the first report of an enzyme able to precipitate silica by condensation of the putative natural substrate, silicic acid. Characterization of the active site indicates a more likely mechanism than previously proposed by modelling of silicatein for the condensation of alkoxysilanes. Using these chimaeras, it will now be possible to synthesize silica materials from aqueous solution at neutral pH, enabling the co-encapsulation of sensitive biological molecules. The work is immediately relevant to groups studying biomineralization processes and groups synthesizing novel silica structures for application as functional materials, such as enzyme immobilization.
LanguageEnglish
PagesA65-A65
JournalJournal of Pharmacy and Pharmacology
Volume60
Issue numberS1
DOIs
Publication statusPublished - 2008

Fingerprint

Porifera
Silicon Dioxide
Silicic Acid
Silicates
Pharmaceutical Preparations
Siloxanes
Cathepsin L
Pichia
Enzymes
Biotechnology
Immobilization
Glass
Escherichia coli
Proteins

Keywords

  • drug delivery
  • spiky sponges

Cite this

van der Walle, C.F. / Drug delivery inspired by spiky sponges. In: Journal of Pharmacy and Pharmacology. 2008 ; Vol. 60, No. S1. pp. A65-A65.
@article{3b1a7f37e286488fa43b7a2b013c57d4,
title = "Drug delivery inspired by spiky sponges",
abstract = "Silica materials are of interest in biotechnology and drug delivery (Giri et al 2007) but controllable silicate formation is very difficult. Yet a variety of sponge species make highly ordered specific glass structures called spicules (Shimizu et al 1998). Harnessing the processes that underlie this biosynthesis has considerable application. The enzyme silicatein forms part of the organic filament found in spicules, which condenses silicate in situ. Both wild-type and recombinant silicatein have been shown to catalyse the condensation of siloxanes such as tetraethoxysilane (Cha et al 1999). However, neither the wild-type nor recombinant silicatein are amenable to biophysical study due to low levels of protein expression and inclusion body formation when recombinantly expressed in Escherichia coli. We recently reported silicatein -cathepsin L chimaeras with the ability to condense silica from solution. These chimaeras are readily obtained by expression in Pichia pastoris, with yields around 40 mg/L of culture. The 1.5 A ° crystal structure of one of these chimaeras allows us to rationalize the catalytic mechanism of silicic acid condensation (Fairhead et al 2008). This is the first report of an enzyme able to precipitate silica by condensation of the putative natural substrate, silicic acid. Characterization of the active site indicates a more likely mechanism than previously proposed by modelling of silicatein for the condensation of alkoxysilanes. Using these chimaeras, it will now be possible to synthesize silica materials from aqueous solution at neutral pH, enabling the co-encapsulation of sensitive biological molecules. The work is immediately relevant to groups studying biomineralization processes and groups synthesizing novel silica structures for application as functional materials, such as enzyme immobilization.",
keywords = "drug delivery, spiky sponges",
author = "{van der Walle}, C.F.",
year = "2008",
doi = "10.1211/002235708785623444",
language = "English",
volume = "60",
pages = "A65--A65",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
number = "S1",

}

Drug delivery inspired by spiky sponges. / van der Walle, C.F.

In: Journal of Pharmacy and Pharmacology, Vol. 60, No. S1, 2008, p. A65-A65.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Drug delivery inspired by spiky sponges

AU - van der Walle, C.F.

PY - 2008

Y1 - 2008

N2 - Silica materials are of interest in biotechnology and drug delivery (Giri et al 2007) but controllable silicate formation is very difficult. Yet a variety of sponge species make highly ordered specific glass structures called spicules (Shimizu et al 1998). Harnessing the processes that underlie this biosynthesis has considerable application. The enzyme silicatein forms part of the organic filament found in spicules, which condenses silicate in situ. Both wild-type and recombinant silicatein have been shown to catalyse the condensation of siloxanes such as tetraethoxysilane (Cha et al 1999). However, neither the wild-type nor recombinant silicatein are amenable to biophysical study due to low levels of protein expression and inclusion body formation when recombinantly expressed in Escherichia coli. We recently reported silicatein -cathepsin L chimaeras with the ability to condense silica from solution. These chimaeras are readily obtained by expression in Pichia pastoris, with yields around 40 mg/L of culture. The 1.5 A ° crystal structure of one of these chimaeras allows us to rationalize the catalytic mechanism of silicic acid condensation (Fairhead et al 2008). This is the first report of an enzyme able to precipitate silica by condensation of the putative natural substrate, silicic acid. Characterization of the active site indicates a more likely mechanism than previously proposed by modelling of silicatein for the condensation of alkoxysilanes. Using these chimaeras, it will now be possible to synthesize silica materials from aqueous solution at neutral pH, enabling the co-encapsulation of sensitive biological molecules. The work is immediately relevant to groups studying biomineralization processes and groups synthesizing novel silica structures for application as functional materials, such as enzyme immobilization.

AB - Silica materials are of interest in biotechnology and drug delivery (Giri et al 2007) but controllable silicate formation is very difficult. Yet a variety of sponge species make highly ordered specific glass structures called spicules (Shimizu et al 1998). Harnessing the processes that underlie this biosynthesis has considerable application. The enzyme silicatein forms part of the organic filament found in spicules, which condenses silicate in situ. Both wild-type and recombinant silicatein have been shown to catalyse the condensation of siloxanes such as tetraethoxysilane (Cha et al 1999). However, neither the wild-type nor recombinant silicatein are amenable to biophysical study due to low levels of protein expression and inclusion body formation when recombinantly expressed in Escherichia coli. We recently reported silicatein -cathepsin L chimaeras with the ability to condense silica from solution. These chimaeras are readily obtained by expression in Pichia pastoris, with yields around 40 mg/L of culture. The 1.5 A ° crystal structure of one of these chimaeras allows us to rationalize the catalytic mechanism of silicic acid condensation (Fairhead et al 2008). This is the first report of an enzyme able to precipitate silica by condensation of the putative natural substrate, silicic acid. Characterization of the active site indicates a more likely mechanism than previously proposed by modelling of silicatein for the condensation of alkoxysilanes. Using these chimaeras, it will now be possible to synthesize silica materials from aqueous solution at neutral pH, enabling the co-encapsulation of sensitive biological molecules. The work is immediately relevant to groups studying biomineralization processes and groups synthesizing novel silica structures for application as functional materials, such as enzyme immobilization.

KW - drug delivery

KW - spiky sponges

UR - http://dx.doi.org/10.1211/002235708785623444

U2 - 10.1211/002235708785623444

DO - 10.1211/002235708785623444

M3 - Article

VL - 60

SP - A65-A65

JO - Journal of Pharmacy and Pharmacology

T2 - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - S1

ER -